Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
- PMID: 33610193
- PMCID: PMC7906709
- DOI: 10.1016/S0140-6736(21)00448-7
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
Comment in
-
COVID-19 vaccine efficacy data: solid enough to delay second dose?Lancet. 2021 Jun 12;397(10291):2248-2249. doi: 10.1016/S0140-6736(21)01046-1. Lancet. 2021. PMID: 34119060 Free PMC article. No abstract available.
References
-
- Public Health England Annex A: Report to JCVI on estimated efficacy of a single dose of Pfizer BioNTech (BNT162b2 mRNA) vaccine and of a single dose of ChAdOx1 vaccine (AZD1222) Dec 22, 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous